...
机译:由蛋白质-肽结合物组成的双组分恶性疟原虫研究疫苗
Program on Developmental and Molecular Immunity, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892;
Program on Developmental and Molecular Immunity, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892;
Program on Developmental and Molecular Immunity, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892;
Program on Developmental and Molecular Immunity, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892;
Program on Developmental and Molecular Immunity, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892;
Department of Pathology, Langone Medical Center, New York University School of Medicine, NY 10016;
Department of Pathology, Langone Medical Center, New York University School of Medicine, NY 10016;
Department of Pathology, Langone Medical Center, New York University School of Medicine, NY 10016;
Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Disease, National Institutes of Health, Rockville, MD 20852;
Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Disease, National Institutes of Health, Rockville, MD 20852;
Program on Developmental and Molecular Immunity, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892;
Program on Developmental and Molecular Immunity, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892;
Program on Developmental and Molecular Immunity, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892;
Program on Developmental and Molecular Immunity, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892;
malaria; circumsporozoite protein; Asn-Ala-Asn-Pro; plasmodium falciparum ookinete surface protein 25;
机译:一期测试由表达恶性疟原虫环子孢子表位的乙型肝炎病毒核心颗粒组成的疟疾疫苗
机译:包含与绿脓杆菌毒素A缀合的环子孢子蛋白重复区肽的恶性疟原虫疫苗的安全性,免疫原性和功效。
机译:载体选择对恶性疟原虫环子孢子蛋白结合疫苗免疫原性的影响。
机译:疟疾疫苗候选疟原虫的免疫原性是恶魔植物在枯草芽孢杆菌中表达的疟原虫候选疟原虫疟原虫表面蛋白5(PFMSP5)
机译:恶性疟原虫环子孢子蛋白的变异:对疫苗开发的影响。
机译:由蛋白质-肽结合物组成的双组分恶性疟原虫研究疫苗
机译:由蛋白质-肽结合物组成的双组分恶性疟原虫研究疫苗
机译:天然恶性疟原虫疟疾免疫的发展:恶性疟原虫疫苗1抗原的抗体(R32tet32)